SAFI BIOSOLUTIONS UK LIMITED - CARLISLE
Company Profile | Company Filings |
Overview
SAFI BIOSOLUTIONS UK LIMITED is a Private Limited Company from CARLISLE ENGLAND and has the status: Active.
SAFI BIOSOLUTIONS UK LIMITED was incorporated 3 years ago on 24/03/2021 and has the registered number: 13290285. The accounts status is TOTAL EXEMPTION FULL and accounts are next due on 30/09/2024.
SAFI BIOSOLUTIONS UK LIMITED was incorporated 3 years ago on 24/03/2021 and has the registered number: 13290285. The accounts status is TOTAL EXEMPTION FULL and accounts are next due on 30/09/2024.
SAFI BIOSOLUTIONS UK LIMITED - CARLISLE
This company is listed in the following categories:
72110 - Research and experimental development on biotechnology
72110 - Research and experimental development on biotechnology
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
31 / 12 | 31/12/2022 | 30/09/2024 |
Registered Office
JAMES WATSON HOUSE MONTGOMERY WAY
CARLISLE
CA1 2UU
ENGLAND
This Company Originates in : United Kingdom
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
15/03/2023 | 29/03/2024 |
Map
ENGLAND
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
MR KYLE JAMES MEETZE | Jul 1971 | American | Director | 2022-03-17 | CURRENT |
DR ROBERT JAMES THOMAS | Jun 1979 | British | Director | 2021-03-24 | CURRENT |
KYLE JAMES MEETZE | Jan 1972 | American | Director | 2021-03-24 UNTIL 2022-03-17 | RESIGNED |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Safi Biosolutions, Inc | 2021-03-24 - 2022-09-21 | Cambridge |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
SAFI BIOSOLUTIONS UK LIMITED | 2023-07-20 | 31-12-2022 | £284,950 Cash £246,977 equity |
SAFI BIOSOLUTIONS UK LIMITED | 2022-12-15 | 31-03-2022 | £231,054 Cash £136,179 equity |